Literature DB >> 28861166

YKL-40 promotes the migration and invasion of prostate cancer cells by regulating epithelial mesenchymal transition.

Hailong Hao1,2, Lei Wang3, Huiqing Chen2, Liwu Xie4, Tao Bai5, Hongyu Liu2, Dongwen Wang1.   

Abstract

OBJECTIVE: This study aims to observe the expression of YKL-40 in prostate cancer and whether YKL-40 can affect the migration and invasion of tumor cells by regulating epithelial mesenchymal transition.
METHODS: We collected 14 cases of prostate cancer tissues and adjacent tissues in this study. The expression levels of YKL-40 in the tissues were analyzed by western blotting and immunohistochemical methods. The expression of YKL-40 in human prostate cancer cell line DU145 and PC3 was detected by fluorescence quantitative PCR and western blotting methods. The expression levels of YKL-40 in different cells were up-regulated or down- regulated by lentivirus to observe the changes of cell migration and invasion. The expression levels of EMT related genes were analyzed by RT-PCR and Western blotting methods.
RESULTS: The expression level of YKL-40 in prostate cancer tissues was significantly higher than that in adjacent tissues (P<0.01), and it was higher in DU145 cells than that in PC3 cells (P<0.05). The expression level of YKL-40 was positively correlated with cell migration and invasion. YKL-40 can regulate the expression of EMT related genes (Twist, Snail, Slug, N-cadherin, Vimentin and E-cadherin).
CONCLUSIONS: The expression level of YKL-40 was positively correlated with the migration and invasion of prostate cells, it affects cancer metastasis by regulating EMT.

Entities:  

Keywords:  RT-PCR; YKL-40; epithelial mesenchymal transition (EMT); immunohistochemistry; prostate cancer; western blotting

Year:  2017        PMID: 28861166      PMCID: PMC5575189     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  24 in total

1.  CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.

Authors:  Bo Mi Ku; Yeon Kyung Lee; Jinhyun Ryu; Joo Yeon Jeong; Jungil Choi; Keyoung Mi Eun; Hye Young Shin; Dong Gyu Kim; Eun Mi Hwang; Jae Cheal Yoo; Jae-Yong Park; Gu Seob Roh; Hyun Joon Kim; Gyeong Jae Cho; Wan Sung Choi; Sun Ha Paek; Sang Soo Kang
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

Review 2.  Novel secondary hormonal therapy in advanced prostate cancer: an update.

Authors:  Eliezer M Van Allen; Charles J Ryan
Journal:  Curr Opin Urol       Date:  2009-05       Impact factor: 2.309

3.  Circulating tumor necrosis factor-α and YKL-40 level is associated with remission status following salvage therapy in relapsed non-Hodgkin lymphoma.

Authors:  Tarec C El-Galaly; Anders E Bilgrau; Eva Gaarsdal; Tobias W Klausen; Lars M Pedersen; Kaspar R Nielsen; John Bæch; Martin Bøgsted; Karen Dybkær; Julia S Johansen; Hans E Johnsen
Journal:  Leuk Lymphoma       Date:  2015-02-24

Review 4.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

5.  Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma.

Authors:  Ralph A Francescone; Steve Scully; Michael Faibish; Sherry L Taylor; Dennis Oh; Luis Moral; Wei Yan; Brooke Bentley; Rong Shao
Journal:  J Biol Chem       Date:  2011-03-08       Impact factor: 5.157

6.  Association of serum YKL-40 level with tumor burden and metastatic stage of prostate cancer.

Authors:  Enver Özdemir; Tarık Çiçek; Mehmet Onur Kaya
Journal:  Urol J       Date:  2012       Impact factor: 1.510

Review 7.  Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks.

Authors:  Javier Vaquero; Nathalie Guedj; Audrey Clapéron; Thanh Huong Nguyen Ho-Bouldoires; Valérie Paradis; Laura Fouassier
Journal:  J Hepatol       Date:  2016-09-26       Impact factor: 25.083

8.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

Review 9.  Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer.

Authors:  Omar Elaskalani; Norbaini Binti Abdol Razak; Marco Falasca; Pat Metharom
Journal:  World J Gastrointest Oncol       Date:  2017-01-15

10.  Tumor-derived mural-like cells coordinate with endothelial cells: role of YKL-40 in mural cell-mediated angiogenesis.

Authors:  R Francescone; N Ngernyuang; W Yan; B Bentley; R Shao
Journal:  Oncogene       Date:  2013-05-13       Impact factor: 9.867

View more
  7 in total

1.  YKL-40 mediates airway remodeling in asthma via activating FAK and MAPK signaling pathway.

Authors:  Yu Sun; Zhaoquan Shi; Bing Liu; Xian'Gui Li; Ge Li; Feng Yang; Hao Tang
Journal:  Cell Cycle       Date:  2020-04-14       Impact factor: 4.534

2.  Functional variant of CHI3L1 gene is associated with neck metastasis in oral cancer.

Authors:  Chun-Wen Su; Mu-Kuan Chen; Wei-Chen Hung; Shun-Fa Yang; Chun-Yi Chuang; Chiao-Wen Lin
Journal:  Clin Oral Investig       Date:  2018-10-19       Impact factor: 3.573

3.  LncRNA KCNQ1OT1 Promotes Proliferation, Invasion and Metastasis of Prostate Cancer by Regulating miR-211-5p/CHI3L1 Pathway.

Authors:  Hailong Hao; Huiqing Chen; Liwu Xie; Hongyu Liu; Dongwen Wang
Journal:  Onco Targets Ther       Date:  2021-03-03       Impact factor: 4.147

4.  CdGAP promotes prostate cancer metastasis by regulating epithelial-to-mesenchymal transition, cell cycle progression, and apoptosis.

Authors:  Chahat Mehra; Ji-Hyun Chung; Yi He; Mónica Lara-Márquez; Marie-Anne Goyette; Nadia Boufaied; Véronique Barrès; Véronique Ouellet; Karl-Phillippe Guérard; Carine Delliaux; Fred Saad; Jacques Lapointe; Jean-François Côté; David P Labbé; Nathalie Lamarche-Vane
Journal:  Commun Biol       Date:  2021-09-07

5.  Androgen receptor regulates eIF5A2 expression and promotes prostate cancer metastasis via EMT.

Authors:  Yuancai Zheng; Ping Li; Hang Huang; Xueting Ye; Wei Chen; Guodong Xu; Fangyi Zhang
Journal:  Cell Death Discov       Date:  2021-12-04

6.  YKL-40 promotes invasion and metastasis of bladder cancer by regulating epithelial mesenchymal transition.

Authors:  Hailong Hao; Huiqing Chen; Liwu Xie; Hongyu Liu
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 7.  Chitinase-3 like-protein-1 function and its role in diseases.

Authors:  Ting Zhao; Zhongping Su; Yingchang Li; Xiaoren Zhang; Qiang You
Journal:  Signal Transduct Target Ther       Date:  2020-09-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.